Fleury receives Brazilian nod to acquire Hermes Pardini
Medical laboratory firm Fleury has received Brazilian antitrust approval, without conditions, to acquire rival Hermes Pardini. The companies still need to wait 15 days after the publication of the decision before...To view the full article, register now.
Already a subscriber? Click here to view full article